Homocysteine, Folate, and Vitamin B 12 Levels and Vertebral Fracture Risk in Postmenopausal Women

Journal of Clinical Densitometry

Volumn 15, Issue 3, 2012, Pages 328-333

  El Maghraoui, Abdellah ^a   Ghozlani, Imad ^a   Mounach, Aziza ^a   Rezqi, Asmaa ^a   Oumghar, Khalid ^a   Achemlal, Lahsen ^a   Bezza, Ahmed ^a   Ouzzif, Zhor ^a  

^a MILITARY HOSPITAL MOHAMMED V   (Morocco)

Author keywords

Folate; Homocysteine; Osteoporosis; Vertebral fracture; Vitamin B 12

Indexed keywords

CALCIUM; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGE; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; BODY WEIGHT; BONE DENSITOMETRY; BONE DENSITY; CALCIUM BLOOD LEVEL; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE ASSOCIATION; FEMALE; FEMUR FRACTURE; FOLIC ACID BLOOD LEVEL; FRAGILITY FRACTURE; HIGH RISK POPULATION; HUMAN; HYPERHOMOCYSTEINEMIA; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPINE FRACTURE; VERTEBRA FRACTURE; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; RISK ASSESSMENT; SPINAL FRACTURES; VITAMIN B 12;

EID: 84864305147     PISSN: 10946950     EISSN: 15590747     Source Type: Journal    
DOI: 10.1016/j.jocd.2011.12.001     Document Type: Article

References (36)

1. El Maghraoui A., Koumba B.A., Jroundi I., et al. Epidemiology of hip fractures in 2002 in Rabat, Morocco. Osteoporos Int 2005, 16:597-602.
2. Lentle B.C., Brown J.P., Khan A., et al. Recognizing and reporting vertebral fractures: reducing the risk of future osteoporotic fractures. Can Assoc Radiol J 2007, 58:27-36.
3. Fechtenbaum J., Cropet C., Kolta S., et al. Reporting of vertebral fractures on spine X-rays. Osteoporos Int 2005, 16:1823-1826.
4. El Maghraoui A., Roux C. DXA scanning in clinical practice. QJM 2008, 101:605-617.
5. El Maghraoui A., Morjane F., Nouijai A., et al. Vertebral fracture assessment in Moroccan women: prevalence and risk factors. Maturitas 2009, 62:171-175.
6. El Maghraoui A., Mounach A., Gassim S., Ghazi M. Vertebral fracture assessment in healthy men: prevalence and risk factors. Bone 2008, 43:544-548.
7. Davison K.S., Kendler D.L., Ammann P., et al. Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond. Am J Med 2009, 122:992-997.
8. Wainwright S.A., Marshall L.M., Ensrud K.E., et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 2005, 90:2787-2793.
9. Kanis J.A., Johansson H., Oden A., McCloskey E.V. Assessment of fracture risk. Eur J Radiol 2009, 71:392-397.
10. Garnero P., Sornay-Rendu E., Claustrat B., Delmas P.D. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 2000, 15:1526-1536.
11. Herrmann M., Widmann T., Herrmann W. Homocysteine-a newly recognised risk factor for osteoporosis. Clin Chem Lab Med 2005, 43:1111-1117.
12. Kuo H.K., Sorond F.A., Chen J.H., et al. The role of homocysteine in multisystem age-related problems: a systematic review. J Gerontol A Biol Sci Med Sci 2005, 60:1190-1201.
13. Grieco A.J. Homocystinuria: pathogenetic mechanisms. Am J Med Sci 1977, 273:120-132.
14. Leboff M.S., Narweker R., LaCroix A., et al. Homocysteine levels and risk of hip fracture in postmenopausal women. J Clin Endocrinol Metab 2009, 94:1207-1213.
15. McLean R.R., Hannan M.T. B vitamins, homocysteine, and bone disease: epidemiology and pathophysiology. Curr Osteoporos Rep 2007, 5:112-119.
16. Blouin S., Thaler H.W., Korninger C., et al. Bone matrix quality and plasma homocysteine levels. Bone 2009, 44:959-964.
17. Herrmann M., Umanskaya N., Wildemann B., et al. Accumulation of homocysteine by decreasing concentrations of folate, vitamin B12 and B6 does not influence the activity of human osteoblasts in vitro. Clin Chim Acta 2007, 384:129-134.
18. Herrmann M., Widmann T., Colaianni G., et al. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem 2005, 51:2348-2353.
19. Ouzzif Z, Oumghar K, Sbai K, et al. Relation of plasma total homocysteine, folate and vitamin B12 levels to bone mineral density in Moroccan healthy postmenopausal women. Rheumatol Int, in press.
20. El Maghraoui A., Do Santos Zounon A.A., Jroundi I., et al. Reproducibility of bone mineral density measurements using dual X-ray absorptiometry in daily clinical practice. Osteoporos Int 2005, 16:1742-1748.
21. Genant H.K., Jergas M., Palermo L., et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1996, 11:984-996.
22. Vallarta-Ast N., Krueger D., Wrase C., et al. An evaluation of densitometric vertebral fracture assessment in men. Osteoporos Int 2007, 18:1405-1410.
23. Grigoryan M., Guermazi A., Roemer F.W., et al. Recognizing and reporting osteoporotic vertebral fractures. Eur Spine J 2003, 12(Suppl 2):S104-S112.
24. Guermazi A., Mohr A., Grigorian M., et al. Identification of vertebral fractures in osteoporosis. Semin Musculoskelet Radiol 2002, 6:241-252.
25. McLean R.R., Jacques P.F., Selhub J., et al. Plasma B vitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women. J Clin Endocrinol Metab 2008, 93:2206-2212.
26. van Meurs J.B., Dhonukshe-Rutten R.A., Pluijm S.M., et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004, 350:2033-2041.
27. Sato Y., Honda Y., Iwamoto J., et al. Homocysteine as a predictive factor for hip fracture in stroke patients. Bone 2005, 36:721-726.
28. Sato Y., Iwamoto J., Kanoko T., Satoh K. Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease. Am J Med 2005, 118:1250-1255.
29. Herrmann M., Peter Schmidt J., Umanskaya N., et al. The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review. Clin Chem Lab Med 2007, 45:1621-1632.
30. Zhu K., Beilby J., Dick I.M., et al. The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women. Osteoporos Int 2009, 20:1183-1191.
31. Rhew E.Y., Lee C., Eksarko P., et al. Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus. J Rheumatol 2008, 35:230-236.
32. Shiraki M., Kuroda T., Shiraki Y., et al. Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment. J Bone Miner Metab 2011, 29:62-70.
33. Perier M.A., Gineyts E., Munoz F., et al. Homocysteine and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int 2007, 18:1329-1336.
34. Gjesdal C.G., Vollset S.E., Ueland P.M., et al. Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the Hordaland Homocysteine Study. J Bone Miner Res 2007, 22:747-756.
35. Ravaglia G., Forti P., Maioli F., et al. Folate, but not homocysteine, predicts the risk of fracture in elderly persons. J Gerontol A Biol Sci Med Sci 2005, 60:1458-1462.
36. Cagnacci A., Bagni B., Zini A., et al. Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. Bone 2008, 42:314-320.